In Vitro Activities of Tigecycline, Minocycline, and Colistin-Tigecycline Combination against Multi- and Pandrug-Resistant Clinical Isolates of Acinetobacter baumannii Group

被引：59
作者：
Arroyo, Luis A. [1 ]
Mateos, Ingeborg [1 ]
Gonzalez, Veronica [1 ]
Aznar, Javier [1 ]
机构：
[1] Virgen Rocio Univ Hosp, Clin Microbiol Serv, Seville, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 03期
关键词：
PAN-RESISTANT; INFECTIONS; THERAPY;
D O I：
10.1128/AAC.01097-08
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1295 / 1296
页数：2
相关论文
共 13 条
[1]   Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline [J].
Anthony, Kara B. ;
Fishman, Neil O. ;
Linkin, Darren R. ;
Gasink, Leanne B. ;
Edelstein, Paul H. ;
Lautenbach, Ebbing .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (04) :567-570
[2]   Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii [J].
Arroyo, LA ;
García-Curiel, A ;
Pachón-Ibañez, ME ;
Llanos, AC ;
Ruiz, M ;
Pachón, J ;
Aznar, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (02) :903-905
[3]   Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy [J].
Hawley, Joshua S. ;
Murray, Clinton K. ;
Jorgensen, James H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) :351-352
[4]   Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections:: a review of the scientific evidence [J].
Karageorgopoulos, Drosos E. ;
Kelesidis, Theodore ;
Kelesidis, Iosif ;
Falagas, Matthew E. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) :45-55
[5]   Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study [J].
Matthaiou, Dimitrios K. ;
Michalopoulos, Argyris ;
Rafailidis, Petros I. ;
Karageorgopoulos, Drosos E. ;
Papaioannou, Vassiliki ;
Ntani, Georgia ;
Samonis, George ;
Falagas, Mafthew E. .
CRITICAL CARE MEDICINE, 2008, 36 (03) :807-811
[6]   Acinetobacter baumannii bloodstream infection while receiving tigecycline:: a cautionary report [J].
Peleg, Anton Y. ;
Potoski, Brian A. ;
Rea, Rhonda ;
Adams, Jennifer ;
Sethi, Jigme ;
Capitano, Blair ;
Husain, Shahid ;
Kwak, Eun J. ;
Bhat, Sunil V. ;
Paterson, David L. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (01) :128-131
[7]   Acinetobacter baumannii:: Emergence of a successful pathogen [J].
Peleg, Anton Y. ;
Seifert, Harald ;
Paterson, David L. .
CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (03) :538-582
[8]   In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis [J].
Petersen, PJ ;
Labthavikul, P ;
Jones, CH ;
Bradford, PA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) :573-576
[9]  
Reis AO, 2003, EMERG INFECT DIS, V9, P1025
[10]   Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology [J].
Sands, M. ;
McCarter, Y. ;
Sanchez, W. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (07) :521-522
12